MARKET WIRE NEWS

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-11 10:00:54 ET

Humacyte, Inc. (HUMA)

Q2 2025 Earnings Call

August 11, 2025 8:00 A.M. ET

Company Participants

Dale A. Sander - CFO, Chief Corporate Development Officer & Treasurer

Laura E. Niklason - Founder, President, CEO & Director

William John Scheessele - Chief Commercial Officer

Conference Call Participants

Bruce David Jackson - The Benchmark Company, LLC, Research Division

Joshua Thomas Jennings - TD Cowen, Research Division

Ryan Benjamin Zimmerman - BTIG, LLC, Research Division

Swayampakula Ramakanth - H.C. Wainwright & Co, LLC, Research Division

Thomas Johnson - Lifesci Advisors, LLC

Presentation

Operator

Good morning, ladies and gentlemen, and welcome to the Humacyte Second Quarter 2025 Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Tom Johnson with Lifesci Advisors. Please go ahead....

Read the full article on Seeking Alpha

For further details see:

Humacyte, Inc. (HUMA) Q2 2025 Earnings Call Transcript
Humacyte Inc. Warrant

NASDAQ: HUMAW

HUMAW Trading

0.02% G/L:

$0.107 Last:

200 Volume:

$0.10698 Open:

mwn-ir Ad 300

HUMAW Latest News

HUMAW Stock Data

$247,325,345
156,832,240
N/A
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Durham

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App